Rochester, NY (PRWEB) April 08, 2014
The Center for the Biology of Chronic Disease (CBCD) has learned that the European Commission held a summit on Chronic Diseases. The major goals of the summit were “to learn how the pressure of the expanding burden of chronic diseases on health systems (can) be reduced and how can available resources be invested in the most efficient way, and which prevention measures are the most cost-effective in the short and in the long term, and how could they be implemented?” (1) The CBCD would first like to congratulate the European Commission on putting emphasis on chronic diseases. However, the CBCD believes that participants will greatly benefit from reading Dr. Polansky’s book on the origin of chronic disease. Dr. Polansky’s book was published by The CBCD and can be freely downloaded at the following link:
Dr. Polansky’s book received high praise from leading scientists. For example, Dr. Sivasubramanian Baskar, PhD of the United States National Cancer Institute (NIH) said “I wish to congratulate Dr. Hanan Polansky for his scientific bravery to take such a unique, novel approach to further stimulate our understanding of the origin and establishment of chronic diseases. The philosophy underscored is an excellent one ... The amazing correlation between theoretical predictions and observed in vivo effects seem to bring us a step closer to a deeper understanding of such complex biologic processes.” (See the CBCD, from 2008) (2). More than fifty additional reviews recommending the book can be found here:
Dr. Polansky’s book presents a theory. “The theory identifies the origin of many chronic diseases, such as atherosclerosis, stroke, cancer, obesity, diabetes, multiple sclerosis, lupus, thyroiditis, osteoarthritis, rheumatoid arthritis, and alopecia.” (See Microcompetition with Foreign DNA and the Origin of Chronic Disease, published in 2003) (3). Dr. Polansky’s theory further explains how foreign DNA fragments can cause these, and many other major diseases. The book has been read by more than 5,000 scientists around the world, and has been reviewed in more than 20 leading scientific journals.
The theory, in short, discusses how foreign DNA fragments, called N-boxes, cause most major diseases. For example, “The theory describes the effect of Foreign DNA fragments that include the cis-regulatory element, called an N-box, on transcription of cellular genes. Consider foreign N-boxes that entered the body naturally, through, for instance, an infection or digestion, or artificially, through, for instance, an injection of some treatment. The foreign N-boxes attract the transcription complex GABP∙p300. Since the complex is a scarce genetic resource, the foreign N-boxes decrease the availability of this complex to cellular genes.”
What is the result of Microcompetition?
The genes that are transactivated by the GABP∙p300 complex produce fewer proteins, and the genes that are suppressed by this complex produce more proteins. The abnormal levels of these cellular proteins cause a disease. It is interesting that many common viruses that establish a latent infection have strong N-boxes in their promoter/enhancer. They include the Epstein-Barr virus (EBV), Cytomegalovirus (CMV), Herpes Simplex virus (HSV), Varicella Zoster virus (VZV), Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), and the Human Papillomavirus (HPV). In fact, the CMV has the strongest promoter/enhancer known to science. Liu et al. showed that the CMV promoter/enhancer, which includes the N-box, is more than 150-fold stronger than the promoter of the platelet-derived growth factor-b chain (PDGF-b) gene.” (See Pharmacology & Pharmacy, from March 2014) (4). The Microcompetition theory predicts that a latent infection with CMV will cause a decrease in PDGF-b transcription, a decrease in the concentration of the PDGF-b protein, and disease.
In light of the discovery of microcompetition with foreign DNA, the CBCD especially encourages government officials, healthcare managers, physicians, virologists, biologists, geneticists, and scientists to obtain a copy of Dr. Hanan Polansky's book and read it.
The CBCD endorses Dr. Polansky’s theory and invites interested parties to contact us on this issue.
For more information on the Center for the Biology of Chronic Disease, or to schedule an interview with Dr. Polansky, please visit http://www.cbcd.net or call 585-250-9999.
(1) European Commission - Public Health - Major and Chronic Diseases- Chronic Diseases Summit.
(2) CBCD - Sivasubramanian Baskar, PhD - Review. Last updated in 2008.
(3) Microcompetition with Foreign DNA and the Origin of Chronic Disease. Published in 2003.
(4) Gene-Eden-VIR Decreased Physical and Mental Fatigue in a Post Marketing Clinical Study That Followed FDA Guidelines; Results Support Microcompetition Theory. Published in March 2014.
The Center for the Biology of Chronic Disease (CBCD, http://www.cbcd.net) is a research center recognized by the IRS as a 501(c)(3) non-for-profit organization. The mission of the CBCD is to advance the research on the biology of chronic diseases, and to accelerate the discovery of treatments for these diseases.
The CBCD published the “Purple” book entitled “Microcompetition with Foreign DNA and the Origin of Chronic Disease” written by Dr. Hanan Polansky. The book presents Dr. Polansky’s highly acclaimed scientific theory on the relationship between the DNA of latent (chronic) viruses and the onset of chronic diseases.
Dr. Polansky’s book is available as a free download from the CBCD website.